Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 3, 2004, Pages 459-467

  Pickering, W ^a   Gray, E ^a   Goodall, A H ^b   Ran, S ^c   Thorpe, P E ^c   Barrowcliffe, T W ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Coagulation; Phospholipid; Procoagulant activity; T cells; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CANCER PROCOAGULANT; CELL SURFACE PROTEIN; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID DERIVATIVE; PROPIDIUM IODIDE; PROTHROMBIN; THROMBOPLASTIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MALE; MONOCYTE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTHROMBIN TIME; T LYMPHOBLAST; CELL LINE; CELL MEMBRANE; CYTOLOGY; LEUKEMIA CELL LINE; PHYSIOLOGY; T LYMPHOCYTE;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; HUMANS; JURKAT CELLS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; T-LYMPHOCYTES; THROMBOPLASTIN;

EID: 6944222765     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00607.x     Document Type: Article

References (33)

1. Trousseau A. Phlegmasia alba dolens; in Clinique medicale de l'Hotel-Dieu de Paris. Bailliere 1865; 3: 654-712.
2. Piccioli A, Prandoni P. Venous thromboembolism as first manifestation of cancer. Acta Haematol 2001; 106: 13-7.
3. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1998; 318: 404-7.
4. Delmas PD, Bjarnason NH, Mitlkak BH, Ravoux AC, Shah AS, Huster WJ. Effects of raloxifene on postmenopausal women. N Engl J Med 1998; 338: 1313-4.
5. Lee AY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999; 25: 137-45.
6. Edwards RL, Silver J, Rickles FR. Human tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.
7. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11: 249-66.
8. Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest 1981; 67: 1665-71.
9. Gordon SG, Mielicki WP. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinolysis 1997; 8: 73-86.
10. Barrowcliffe TW, Marshall DE, Trickett LP, Hubbard AR, Gray E, Thorpe R. Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb Haemost 1989; 62: 880-4.
11. Drexler HG, Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 1999; 13: 835-42.
12. Barrowcliffe TW, Fabregas P, Jardi M, Cancelas J, Rabaneda M, Feiez J. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb Haemost 2002; 87: 442-9.
13. Kemball-Cook G, Tubbs JE, Dawson NJ, Barrowcliffe TW. The behaviour of different factor VIII concentrates in a chromogenic factor X-activating system. Br J Haematol 1993; 84: 273-8.
14. Mielicki WP, Gordon SG. Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant. Blood Coagul Fibrinolysis 1993; 4: 441-6.
15. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-9.
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
17. McGee MP, Li LC. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages. J Biol Chem 1991; 266: 8079-85.
18. Brinkman HJ, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, van Mourik JA. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. Br J Haematol 1994; 87: 332-42.
19. Suzuki M, Ando O, Ohta T, Inufusa H, Adachi T, Yasutomi M. High expression of glycosphingolipids involved in procoagulant activity of cancer cells. Oncol Report 1999; 6: 113-5.
20. Inufusa H, Adachi T, Suzuki M, Ando O, Ohta T, Kurimoto M. Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines. Cancer 1998; 82: 1563-9.
21. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265 4923-8.
22. Blackwood RA, Ernst JD. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J 1990; 266: 195-200.
23. Barrowcliffe TW, Gray E, Kerry PJ, Gutteridge JM. Triglyceride-rich lipoproteins are responsible for thrombin generation induced by lipid peroxides. Thromb Haemost 1984; 52: 7-10.
24. Wang J, Weiss I, Svoboda K, Kwaan HC. Thrombogenic role of cells undergoing apoptosis. Br J Haematol 2001; 115: 382-91.
25. Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Haematol 2001; 106: 33-42.
26. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 1999; 25: 173-82.
27. Falanga A, Barbui T. Coagulopathy of acute promyelocytic leukemia. Acta Haematol 2001; 106: 43-51.
28. Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 2001; 27: 593-604.
29. Kunzelmann-Marche C, Satta N, Toti F, Zhang Y, Nawroth PP, Morrissey JH. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 2000; 83: 282-9.
30. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
31. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6 131-8.
32. Libby P, Mach F, Schonbeck U, Bourcier T, Aikawa M. Regulation of the thrombotic potential of atheroma. Thromb Haemost 1999; 82: 736-41.
33. Edwards RL, Rickles FR. The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992; 29: 202-12.